[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"renal-neoplasma\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:renal-neoplasma":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":4,"acronym":4,"eligibilityCriteria":13,"healthyVolunteers":10,"sex":14,"minAge":15,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100246520",false,"NCT02487550","DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating","Inclusion Criteria:\n\n* Histologically proven renal cell carcinoma\n* Age: \\> 18\n* WHO- ECOG Performance Status 0-1\n* At least one measurable tumor lesions according to the RECIST criteria.\n* Life expectancy more than 3 months\n* Written informed consent\n\nExclusion Criteria:\n\n* Patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal\u002Fsquamous cell carcinomas of the skin).\n* Patients with metastatic disease in the central nervous system (CNS).\n* Patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.\n* Patients with acute or chronic infection including HIV.\n* Patients who are pregnant or nursing.\n* Patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.\n* Patients who receive corticosteroids or other immunosuppressive agents.\n* Patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.","ALL","18 Years","80 Years",{"count":18,"type":19},1200,"ESTIMATED","INTERVENTIONAL",[22],"PHASE2","The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.",[25],"Renal Neoplasma",[27,28],"Renal neoplasma","CIK cells","NOT_YET_RECRUITING","2015-06-29",{"date":32,"type":19},"2015-07-01",{"date":34,"type":4},"2015-08",{"date":36,"type":19},"2030-07",{"name":38,"class":39},"The First People's Hospital of Changzhou","OTHER",""]